Fundamentals of Artificial Intelligence in Healthcare

---

LIVEDHPAMAFace to Face

Saturday, February 10, 2024, 7:30 AM - 3:15 PM, Weill Cornell Medicine-Qatar, Doha, Qatar

As technology rapidly advances, the integration of AI in healthcare is becoming increasingly important and Qatar is recognizing the significance of leveraging AI to enhance patient care, optimize clinical workflows, and improve healthcare outcomes.  This Artificial Intelligence (AI) course is designed to address the knowledge gap among healthcare professionals in Qatar and meet the needs of the community. This one day interactive in person introductory course is scheduled at WCM-Q and open for up to 60 participants.  The target audience are physicians, nurses, dentists and pharmacists. It will cover fundamental AI aspects, ethical issues and challenges and include group discussions in a journal club format

1. 1- Recognize the history of AI and basic definition of AI
2. 2- Outline Fundamental concepts AI, ML and DL
3. 3- Evaluate the performance of AI algorithms and show an awareness of applications of AI and machine learning in the healthcare field
4. 4- Analyze potential challenges and ethical issues associated with building an AI system.
5. 5 - Analyze guided information related to group paper and discuss in a mini journal club style

Early bird rate until January 25, 2024 - QAR 100/ USD 28

Regular fees starting January 26, 2024 - QAR 150/USD 41

Changes or Cancellations

1- Name changes or substitutions are not permitted.
2- All cancellation and refund requests must be made in writing and submitted via email to [email protected].
3- For a full refund of the registration fee, the cancellation requests must be received at least 7 days prior to the session. No refund will be offered for cancellation request thereafter.
4- We will attempt to process the refund within 30 days of receiving any cancellation request.
5- Weill Cornell Medicine-Qatar reserves the right to cancel the course. In the event of a cancellation, the fee deposit will be returned, but we will not be responsible for any other expenses, including restricted or non-refundable airfare or hotel deposits.

REGISTRATION WARNING

Registration for courses managed by Weill Cornell Medicine-Qatar (WCM-Q) can only be completed through WCM-Q's official registration portal. Attendee registrations made through any other sites cannot be honored. WCM-Q is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com, MedConfWorld.com, EventEgg.com, and 10times.com.

Please report any unauthorized websites or solicitations for registrations to  [email protected].

DHP 

Weill Cornell Medicine-Qatar is accredited as a provider of Continuing Medical Education (CME) and Continuing Professional Development (CPD) by the Ministry of Public Health's Department of Healthcare Professions.

This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health's Department of Healthcare Professions-Accreditation Section and is approved for a maximum of 6.25 hours.

ACCME

Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Weill Cornell Medicine-Qatar designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to adhere to the Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias. 

Scientific Planning Committee: Mohammed Yawar, BDS, Phyllis Muffuh Navti, DHSci, Mubashir Wani, MD, Rhealyn Mendoza, BSc, Alaa Abd-Alrazaq, PhD

Have no relevant financial relationship to disclose
Will not be discussing unlabeled/unapproved use of drugs or products

Course Directors: Arfan Ahmed, PhD, Alaa Abd-Alrazaq, PhD

Have no relevant financial relationship to disclose
Will not be discussing unlabeled/unapproved use of drugs or products

Course Faculty: Arfan Ahmed, PhD, Alaa Abd-Alrazaq, PhD, Rawan Al Saad, PhD, Sarah Aziz

Have no relevant financial relationship to disclose
Will not be discussing any unlabeled/unapproved use of drugs or products

Administrative Contact: Sarah Aziz

Has no relevant financial relationship to disclose
Will not be discussing any unlabeled/unapproved use of drugs or products

The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.

Mitigation of Relevant Financial Relationships

Weill Cornell Medicine-Qatar adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Saturday, February 10, 2024